-
A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices
Sep 9, 2025, 16:22 PM -
Cost Trends for Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Management in Relapsed/Refractory Large B-cell Lymphoma (R/R LBCL) Treatment With Axicabtagene Ciloleucel (Axi-cel) in the US
Sep 9, 2025, 16:22 PM -
Leveling the Field: How the MFN Could Transform Drug Pricing
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use and Mortality After Diabetic Ketoacidosis: Insights From Linked Primary- and Secondary-Care Data in the UK
Sep 9, 2025, 16:22 PM -
Breast Cancer Overall Survival in France
Sep 9, 2025, 16:22 PM -
Optimizing Patient-Reported Outcomes in German HTA: Addressing Key Challenges and Methodological Requirements
Sep 9, 2025, 16:22 PM -
The Burden of Patients With Severe Asthma: A Comparison Between Patients Treated With and Eligible for Monoclonal Antibodies Through a Retrospective Observational Analysis of Italian Real-World Data
Sep 9, 2025, 16:22 PM -
Health Economic Evaluations of Prevention and Management Strategies for Cholangiocarcinoma: A Systematic Review
Sep 9, 2025, 16:22 PM -
DII Mentoring Project— Patient Associations as a Catalyst for Quality-Of-Life Improvement and Positive Economic Impact in Inflammatory Bowel Disease
Sep 9, 2025, 16:22 PM -
Natural Language Processing for Identification of Negative Symptoms in Patients With and Without Cognitive Impairment Associated With Schizophrenia (CIAS)
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Rozanolixizumab for the Treatment of Generalized Myasthenia Gravis (gMG) in Greece
Sep 9, 2025, 16:22 PM -
Dupilumab Improves Lung Function and Asthma Control While Reducing Systemic Corticosteroid Use in Patients With Allergic Bronchopulmonary Aspergillosis: The Phase 2 LIBERTY ABPA AIRED Study
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ribociclib With Endocrine Therapy for Treatment With Premenopausal Women With HR Positive HER2 Negative Early Breast Cancer in the UK
Sep 9, 2025, 16:22 PM -
Country-Specific Adaptation of Health Economic Models With Generative AI: A Case Study in Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Viable Rate of Return for Social Impact Bonds Supporting Research and Development of Gene Therapies for Rare Conditions
Sep 9, 2025, 16:22 PM -
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology
Sep 9, 2025, 16:22 PM -
Changes in the Epidemiological Indicators of Female Infertility in Europe 1991-2021
Sep 9, 2025, 16:22 PM -
Development and Validation of a Case Identification Algorithm for Hand Trauma Patients Using Health Administrative Data and the Epidemiology of Hand Trauma in a Universal Healthcare System
Sep 9, 2025, 16:22 PM -
Automated Excel-to-R Conversion of Health Economic Models Using the REEEVR Tool: Results of Alpha Test
Sep 9, 2025, 16:22 PM -
Looking Back to Go Forward: Reintegrating Scientific Considerations Into eCOA Design and Implementation
Sep 9, 2025, 16:22 PM
